University of Dundee

Latest News

October 2009

  • 27 Oct 2009

    CLS once again internationally recognised as one of the best places to work An international poll of scientists has once again named the College of Life Sciences at the University of Dundee as one of the best places to work in life sciences research. The College is among the top three places to work in scientific research in the United Kingdom - second, ahead of the University of Cambridge. It is also the only research institute in Scotland to be named in the list of the top 10 research universities outside the United States.

  • 19 Oct 2009

    College of Life Sciences Principal Investigator, Ron Hay FRSE FMedSci, Professor of Molecular Biology at the Centre for Gene Regulation and Expression has been elected as a Member of the European Molecular Biology Organisation, EMBO.

  • 13 Oct 2009

    SCILLS Scientist receives 1.4 million euros from the European Research Council A scientist at the Scottish Institute for ceLL Signaling (SCILLS) at the College of Life Sciences in Dundee has been awarded a 1.4 million euro grant from the European Research Council to support an innovative research programme that could lead to the development of a novel class of drugs to treat cancer. Dr Thimo Kurz, a Programme Leader within SCILLS at CLS, has received the Starting Grant from the ERC for his research on types of protein modification in human cells.

  • 11 Oct 2009

    College of Life Sciences Principal Investigator, Ron Hay FRSE FMedSci, Professor of Molecular Biology at the Wellcome Trust Centre for Gene Regulation and Expression has been elected as a Member of the European Molecular Biology Organisation, EMBO.

  • 10 Oct 2009

    Scientists have discovered why a group of cancer drugs are so effective in treating the disease. Although they have been used for many years to treat certain tumours, researchers didn’t know how they worked until now. The findings, published in EMBO Reports and presented at the NCRI Cancer Conference, pave the way for the development of a new range of cancer treatments.